One Drop Launches Global Commercial Partnership with Bayer
Vinson & Elkins advised One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, in connection with a $40 million Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world.
has also entered a commercial licensing agreement to use One Drop's platform in
Bayer's global bio-digital efforts in therapeutic areas such as oncology,
cardiovascular disease and women's health.
The V&E corporate team was led by partner
Paul Tobias and counsel Andy Smetana with assistance from associates Ben
Cukerbaum and Vaughn Miller. Also advising was partner Damara Chambers.